These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20713974)

  • 1. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.
    Wadhera RK; Rajkumar SV
    Mayo Clin Proc; 2010 Oct; 85(10):933-42. PubMed ID: 20713974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
    Landgren O; Katzmann JA; Hsing AW; Pfeiffer RM; Kyle RA; Yeboah ED; Biritwum RB; Tettey Y; Adjei AA; Larson DR; Dispenzieri A; Melton LJ; Goldin LR; McMaster ML; Caporaso NE; Rajkumar SV
    Mayo Clin Proc; 2007 Dec; 82(12):1468-73. PubMed ID: 18053453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men.
    Cicero KI; Joffe M; Patel M; Chiuzan C; Pentz A; Ruff P; Lentzsch S; Leng S; Jacobson JS; Rebbeck TR; Neugut AI
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2192-2198. PubMed ID: 36126958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
    Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
    Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.
    Landgren O; Kyle RA; Hoppin JA; Beane Freeman LE; Cerhan JR; Katzmann JA; Rajkumar SV; Alavanja MC
    Blood; 2009 Jun; 113(25):6386-91. PubMed ID: 19387005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition.
    Therneau TM; Kyle RA; Melton LJ; Larson DR; Benson JT; Colby CL; Dispenzieri A; Kumar S; Katzmann JA; Cerhan JR; Rajkumar SV
    Mayo Clin Proc; 2012 Nov; 87(11):1071-9. PubMed ID: 22883742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.
    Landgren O; Gridley G; Turesson I; Caporaso NE; Goldin LR; Baris D; Fears TR; Hoover RN; Linet MS
    Blood; 2006 Feb; 107(3):904-6. PubMed ID: 16210333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
    N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.
    Castaneda-Avila MA; Ulbricht CM; Epstein MM
    Ann Hematol; 2021 Apr; 100(4):855-863. PubMed ID: 33416902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.
    Iwanaga M; Tagawa M; Tsukasaki K; Kamihira S; Tomonaga M
    Mayo Clin Proc; 2007 Dec; 82(12):1474-9. PubMed ID: 18053454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
    Lolin YI; Chow J; Wickham NW
    Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
    Landgren O; Kyle RA; Pfeiffer RM; Katzmann JA; Caporaso NE; Hayes RB; Dispenzieri A; Kumar S; Clark RJ; Baris D; Hoover R; Rajkumar SV
    Blood; 2009 May; 113(22):5412-7. PubMed ID: 19179464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of monoclonal gammopathy with undetermined significance--review].
    Wang XW; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1365-9. PubMed ID: 21129295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
    Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
    J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors.
    Iwanaga M; Tagawa M; Tsukasaki K; Matsuo T; Yokota K; Miyazaki Y; Fukushima T; Hata T; Imaizumi Y; Imanishi D; Taguchi J; Momita S; Kamihira S; Tomonaga M
    Blood; 2009 Feb; 113(8):1639-50. PubMed ID: 18849487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis.
    Landgren O; Weiss BM
    Leukemia; 2009 Oct; 23(10):1691-7. PubMed ID: 19587704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study.
    Gupta R; Dahiya M; Kumar L; Shekhar V; Sharma A; Ramakrishnan L; Sharma OD; Begum A
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e345-e350. PubMed ID: 29980412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.